Ultrasound-guided Microwave Ablation of Benign Thyroid Nodules

The goal of this clinical trial is to learn if microwave ablation of benign thyroid nodules under local anaesthesia is a safe and effective procedure compared to open thyroidectomy. The main questions it aims to answer are: Dose microwave Ablation effectively cause shrinkage of thyroid nodules? Can ablation of selective area of nodules be safely performed under ultrasound guidance, avoiding critical structures including recurrent laryngeal nerve, major vessels and trachea? Researchers will recruit subjects with symptomatic benign thyroid nodules for Microwave Ablation. Participants will: U

Trial Details

NCT ID

NCT07906821

Phase

NA

Sponsor

Chinese University of Hong Kong

Status

RECRUITING

Cancer Type

Thyroid Cancer

Interventions

• ultrasound-guided percutaneous microwave ablation (MWA)

Locations (sample)

• Shatin, Hong Kong|22.38333,114.18333

Key Eligibility Criteria

• Thyroid nodules or dominant nodule of multinodular goitre
• Symptomatic thyroid nodule not less than 2cm
• Benign thyroid nodule confirmed by Fine needle aspiration for cytology (FNAC)

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Thyroid Cancer Trials on Trialify →